KR910002826A - 푸란 유도체 - Google Patents
푸란 유도체 Download PDFInfo
- Publication number
- KR910002826A KR910002826A KR1019890010213A KR890010213A KR910002826A KR 910002826 A KR910002826 A KR 910002826A KR 1019890010213 A KR1019890010213 A KR 1019890010213A KR 890010213 A KR890010213 A KR 890010213A KR 910002826 A KR910002826 A KR 910002826A
- Authority
- KR
- South Korea
- Prior art keywords
- methyl
- salt
- bismuth
- complex
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
내용 없음.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (22)
- 비스무트와 카브복실산의 복합체와 라니티딘 사이에 형성된 염. 또는 이러한 염의 용매화합물.
- 제1항에 있어서, 라니티딘과의 염 형성에 유용한 카르복실기 이외에도, 카르복실산이 분자내에 적어도 3개의 기능기를 갖는 염.
- 제1항에 있어서, 카르복실산이 시트르산, 타르타르산, 에틸렌디아민테트라아세트산, 프로필시트르산 또는 아가리신산인 염.
- 제1항에 있어서, 카르복실산이 시트르산 또는 타르타르산인 염.
- 제1항에 있어서, 카르복실산이 시트르산인 염.
- N-[2-[[[5-[(디메틸아미노)메틸]-2-푸라닐]메틸]티오]에틸]-N′-메틸]-2-니트로-1,1-에텐디아민-2-히드록시-1,2,3-프로판트리카르복실레이트 비스무트(3′)복합체, 및 그의 용매화합물.
- N-[2-[[[5-[(디메틸아미노)메틸]-2-푸라닐]메틸]티오]에틸]-N′-메틸]-2-니트로-1,1-에텐디아민 [R-R*R*)]-2,3-디히드록시부탄디오에이트 비스무트(3′)복합체, 및 그의 용매화합물.
- N-[2-[[[5-[(디메틸아미노)메틸]-2-푸라닐]메틸]티오]에틸]-N′-메틸]-2-니트로-1,1-에텐디아민-2-히드록시-1,2,3-노나데칸 트라카르복실레이트 비스무트(3′)복합체, 및 그의 용매화합물.
- N-[2-[[[5-[(디메틸아미노)메틸]-2-푸라닐]메틸]티오]에틸]-N′-메틸]-2-니트로-1,1-에텐디아민 N,N′-에탄디일비스[N-(카르복시메틸)글리신]비스무(3′)복합체, 및 그의 용매화합물.
- 적어도 1종의 제약상 허용되는 담체 또는 희석제와 함께 제1 내지 9항중 중 어느 하나의 항에 의한 염으로 되는 제약 조성물.
- 제10항에 있어서, 경구 투여에 적합한 형태의 제약 조성물.
- 제10항에 있어서, 정제 형태의 제약 조성물.
- 제11또는 제12항에 있어서, 단위 투여량 당 염 100mg 내지 1g을 함유한 단위 투여량 형태의 제약 조성물.
- 제11 또는 12항에 있어서, 단위 투여량 당 염 100 내지 800mg을 함유한 단위 투여량 형태의 제약 조성물.
- 제11 또는 12항에 있어서, 단위 투여량 당 염 150 내지 600mg을 함유한 단위 투여량 형태의 제약 조성물.
- 제1 내지 9항중 어느 하나의 항에 있어서, 유효치료제로서 사용하기위한 염.
- 라니티딘을 적합한 용매 중에서 비스무트 카르복실산 복합체와 반응시키고, 그리하여 형성된 염을 용액으로부터 분리시키는 것으로 되는, 제1 내지 9항중 어느 하나의 항에 의한 염의 제조 방법.
- 제17항에 있어서, 용매가 물인 방법.
- 제17내지 18항에 있어서, 반응을 승온에서 행하는 방법.
- 제17또는 18항에 있어서, 반응을 40내지 100℃의 온도에서 행하는 방법.
- 라이티딘을 비스무트 카르복실산 복합체와 반응시켜서 제조한, 비스무트와 카르복실산과의 복합체와 라이티딘 사이에 형성된 염 또는 이러한 용매화합물.
- 라니티딘을 비스무트와 시트르산과의 복합체와 반응시키겨 제조한 라니티딘 비스무트 시트레이트 또는 그의 용매화합물.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8817098.0 | 1988-07-18 | ||
GB88-17098.0 | 1988-07-18 | ||
GB888817098A GB8817098D0 (en) | 1988-07-18 | 1988-07-18 | Chemical compounds |
GB89-04686.6 | 1989-03-01 | ||
GB898904686A GB8904686D0 (en) | 1989-03-01 | 1989-03-01 | Chemical compounds |
GB8904686.6 | 1989-03-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR910002826A true KR910002826A (ko) | 1991-02-26 |
KR0122598B1 KR0122598B1 (ko) | 1997-11-13 |
Family
ID=26294175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890010213A KR0122598B1 (ko) | 1988-07-18 | 1989-07-18 | 푸란 유도체 |
Country Status (35)
Country | Link |
---|---|
US (1) | US5008256A (ko) |
JP (1) | JP2523185B2 (ko) |
KR (1) | KR0122598B1 (ko) |
CN (1) | CN1022626C (ko) |
AT (1) | AT398200B (ko) |
AU (1) | AU632052B2 (ko) |
BE (1) | BE1003254A5 (ko) |
CA (1) | CA1332610C (ko) |
CH (1) | CH679582A5 (ko) |
CY (1) | CY1650A (ko) |
DE (1) | DE3923638C2 (ko) |
DK (1) | DK168381B1 (ko) |
EG (1) | EG19368A (ko) |
ES (1) | ES2014175A6 (ko) |
FI (1) | FI90538C (ko) |
FR (1) | FR2634122B1 (ko) |
GB (1) | GB2220937B (ko) |
GR (1) | GR1000431B (ko) |
HK (1) | HK61392A (ko) |
HU (2) | HU206104B (ko) |
IE (1) | IE61076B1 (ko) |
IL (1) | IL91005A (ko) |
IT (1) | IT1231481B (ko) |
LU (2) | LU87557A1 (ko) |
MX (1) | MX174145B (ko) |
MY (1) | MY104055A (ko) |
NL (2) | NL192604C (ko) |
NO (2) | NO176319C (ko) |
NZ (1) | NZ229958A (ko) |
PL (1) | PL162391B1 (ko) |
PT (1) | PT91188B (ko) |
SE (1) | SE468715B (ko) |
SG (1) | SG51992G (ko) |
YU (1) | YU47021B (ko) |
ZW (1) | ZW8689A1 (ko) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3874917T2 (de) * | 1987-03-09 | 1993-03-04 | Procter & Gamble | Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen. |
IL85472A (en) * | 1987-03-09 | 1991-06-30 | Procter & Gamble | Pharmaceutical compositions for treating gastrointestinal disorders |
AU641903B2 (en) * | 1988-10-26 | 1993-10-07 | Glaxo Group Limited | Carboxylic acid derivatives |
GB9004328D0 (en) * | 1990-02-27 | 1990-04-25 | Glaxo Group Ltd | Chemical compounds |
GB9009240D0 (en) * | 1990-04-25 | 1990-06-20 | Glaxo Group Ltd | Chemical compounds |
GB9009437D0 (en) * | 1990-04-26 | 1990-06-20 | Glaxo Group Ltd | Chemical compounds |
DK0540613T3 (da) * | 1990-07-20 | 1996-04-01 | Tillotts Pharma Ag | Produkter og fremgangsmåder til behandling af fordøjelseskanalen |
GB9019875D0 (en) * | 1990-09-11 | 1990-10-24 | Glaxo Group Ltd | Pharmaceutical compositions |
US5192752A (en) * | 1991-01-14 | 1993-03-09 | The Procter & Gamble Company | Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate |
US5128140A (en) * | 1991-01-14 | 1992-07-07 | The Procter & Gamble Company | Swallowable pharmaceutical compositions |
GB9120131D0 (en) * | 1991-09-20 | 1991-11-06 | Glaxo Group Ltd | Medicaments |
DE69228738D1 (de) * | 1991-12-06 | 1999-04-29 | Glaxo Group Ltd | Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten |
AU1671295A (en) * | 1994-12-19 | 1996-07-10 | Lauteral Limited | Combinations of ranitidine hydrochloride-form 1 and bismuth compounds |
CN1177357A (zh) * | 1995-01-26 | 1998-03-25 | 耐克麦德英梅金公司 | 铋化合物 |
GB9501560D0 (en) * | 1995-01-26 | 1995-03-15 | Nycomed Imaging As | Contrast agents |
EP1035192A1 (de) * | 1999-01-26 | 2000-09-13 | Stefan Graichen | Additiv für einen Kühlschmierstoff |
CN1102585C (zh) * | 1999-04-28 | 2003-03-05 | 常州兰陵制药有限公司 | 雷尼替丁枸橼酸铋盐的制备方法 |
US20060100271A1 (en) * | 2004-11-08 | 2006-05-11 | Keith Whitehead | Stabilized aqueous ranitidine compositions |
CN100402514C (zh) * | 2006-08-01 | 2008-07-16 | 丽珠医药集团股份有限公司 | 一种制备枸橼酸铋雷尼替丁的方法 |
CN101484132A (zh) * | 2007-07-09 | 2009-07-15 | 柏树制药公司 | 具有合意口味的雷尼替丁制剂 |
CN102408398B (zh) * | 2011-09-20 | 2012-12-05 | 江苏汉斯通药业有限公司 | 枸橼酸铋雷尼替丁的制备方法 |
US9731999B2 (en) | 2011-09-23 | 2017-08-15 | Iqbal Gill | Chemical admixtures for hydraulic cements |
ES2426539B1 (es) * | 2012-04-18 | 2014-09-09 | Dr Healthcare España, S. L. | Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd) |
CN103896888B (zh) * | 2014-03-28 | 2015-11-18 | 常州兰陵制药有限公司 | 枸橼酸铋雷尼替丁的制备方法 |
EP2929884A1 (en) | 2014-04-11 | 2015-10-14 | Sanovel Ilac Sanayi ve Ticaret A.S. | Pharmaceutical combinations of dabigatran and h2-receptor antagonists |
EP2942058A1 (en) | 2014-05-09 | 2015-11-11 | Sanovel Ilac Sanayi ve Ticaret A.S. | Pharmaceutical combinations of rivaroxaban and H2-receptor antagonists |
CN107382921A (zh) * | 2017-07-28 | 2017-11-24 | 常州兰陵制药有限公司 | 制备枸橼酸铋雷尼替丁的方法 |
WO2022034121A1 (en) | 2020-08-11 | 2022-02-17 | Université De Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1565966A (en) * | 1976-08-04 | 1980-04-23 | Allen & Hanburys Ltd | Aminoalkyl furan derivatives |
FR2531706A1 (fr) * | 1982-08-13 | 1984-02-17 | Sanofi Sa | Benzamides, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant |
BE905235A (fr) * | 1986-08-05 | 1986-12-01 | Hasunor Ag | Ascorbates antagonistes des recepteurs h2 et leur procede de preparation. |
IT1215325B (it) * | 1987-01-07 | 1990-02-08 | Barisintex Sa | Composti antagonisti di recettori -h2 e procedimento per la loro preparazione. |
IL85472A (en) * | 1987-03-09 | 1991-06-30 | Procter & Gamble | Pharmaceutical compositions for treating gastrointestinal disorders |
DE3874917T2 (de) * | 1987-03-09 | 1993-03-04 | Procter & Gamble | Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen. |
DE3710462A1 (de) * | 1987-03-30 | 1988-10-13 | Heumann Pharma Gmbh & Co | Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes |
GB9004328D0 (en) * | 1990-02-27 | 1990-04-25 | Glaxo Group Ltd | Chemical compounds |
GB9009437D0 (en) * | 1990-04-26 | 1990-06-20 | Glaxo Group Ltd | Chemical compounds |
-
1989
- 1989-07-14 CH CH2647/89A patent/CH679582A5/fr not_active IP Right Cessation
- 1989-07-17 CA CA000605843A patent/CA1332610C/en not_active Expired - Fee Related
- 1989-07-17 IE IE230989A patent/IE61076B1/en not_active IP Right Cessation
- 1989-07-17 FR FR8909575A patent/FR2634122B1/fr not_active Expired - Fee Related
- 1989-07-17 FI FI893448A patent/FI90538C/fi not_active IP Right Cessation
- 1989-07-17 US US07/380,378 patent/US5008256A/en not_active Expired - Lifetime
- 1989-07-17 ZW ZW86/89A patent/ZW8689A1/xx unknown
- 1989-07-17 GR GR890100454A patent/GR1000431B/el not_active IP Right Cessation
- 1989-07-17 PT PT91188A patent/PT91188B/pt not_active IP Right Cessation
- 1989-07-17 GB GB8916288A patent/GB2220937B/en not_active Expired - Lifetime
- 1989-07-17 YU YU142789A patent/YU47021B/sh unknown
- 1989-07-17 IT IT8948196A patent/IT1231481B/it active Protection Beyond IP Right Term
- 1989-07-17 ES ES8902517A patent/ES2014175A6/es not_active Expired - Fee Related
- 1989-07-17 LU LU87557A patent/LU87557A1/fr active Protection Beyond IP Right Term
- 1989-07-17 PL PL28062889A patent/PL162391B1/pl unknown
- 1989-07-17 LU LU88722C patent/LU88722I2/fr unknown
- 1989-07-17 AU AU38178/89A patent/AU632052B2/en not_active Ceased
- 1989-07-17 HU HU893595A patent/HU206104B/hu unknown
- 1989-07-17 MX MX1682989A patent/MX174145B/es unknown
- 1989-07-17 NL NL8901840A patent/NL192604C/nl not_active IP Right Cessation
- 1989-07-17 EG EG34289A patent/EG19368A/xx active
- 1989-07-17 DK DK351789A patent/DK168381B1/da not_active IP Right Cessation
- 1989-07-17 AT AT0172889A patent/AT398200B/de not_active IP Right Cessation
- 1989-07-17 CN CN89104959A patent/CN1022626C/zh not_active Expired - Fee Related
- 1989-07-17 MY MYPI89000969A patent/MY104055A/en unknown
- 1989-07-17 SE SE8902550A patent/SE468715B/sv not_active IP Right Cessation
- 1989-07-17 NZ NZ229958A patent/NZ229958A/xx unknown
- 1989-07-17 IL IL9100589A patent/IL91005A/en not_active IP Right Cessation
- 1989-07-17 JP JP1184402A patent/JP2523185B2/ja not_active Expired - Lifetime
- 1989-07-17 NO NO892936A patent/NO176319C/no not_active IP Right Cessation
- 1989-07-17 BE BE8900773A patent/BE1003254A5/fr not_active IP Right Cessation
- 1989-07-17 DE DE3923638A patent/DE3923638C2/de not_active Expired - Fee Related
- 1989-07-18 KR KR1019890010213A patent/KR0122598B1/ko not_active IP Right Cessation
-
1992
- 1992-05-09 SG SG519/92A patent/SG51992G/en unknown
- 1992-08-13 HK HK613/92A patent/HK61392A/xx not_active IP Right Cessation
- 1992-12-11 CY CY1650A patent/CY1650A/xx unknown
-
1995
- 1995-06-12 HU HU95P/P00186P patent/HU211173A9/hu unknown
-
1997
- 1997-12-18 NL NL970046C patent/NL970046I2/nl unknown
-
1998
- 1998-02-05 NO NO1998007C patent/NO1998007I1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR910002826A (ko) | 푸란 유도체 | |
US4160827A (en) | Metronidazole phosphate and salts | |
JPS5513275A (en) | Prodrug of non-steroid anti-inflammatory drug having improved absorption and anti-inflammatory drug composition comprising it | |
KR900003151A (ko) | 화합물 | |
EP1083887B1 (en) | Pharmaceutical compositions for the treatment of ulcers | |
HU209308B (en) | Process for producing codeine salt of substituted carboxylic acid | |
KR910021394A (ko) | 카르복실산 유도체 | |
KR920005984A (ko) | 푸란 유도체를 함유하는 제약 조성물 | |
RU94040869A (ru) | Фармацевтические композиции, содержащие соли ранитидина и карбоксилаты висмута, и способ их получения | |
SE7601337L (sv) | Antibiotika och forfarande for framstellning derav | |
DK150604B (da) | Analogifremgangsmaade til fremstilling af calciumoxaprozin | |
ES8203882A1 (es) | Un procedimiento para la preparacion de 1-(8-quinole- il)-2-pirrolidinona y sus sales de adicion de acido | |
US4393081A (en) | Methyl 3-acetamido-2-(5-methoxy-indol-3-yl) propanoate and hypotensive use thereof | |
KR930023338A (ko) | 데포우 제제 | |
GB1569421A (en) | Penicillin compositions | |
WO1995010274A1 (en) | Aqueous pharmaceutical composition | |
FI870045A0 (fi) | Nya kvaevearylmetoxi-tiofenderivat och deras syraadditionssalter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat. | |
KR880005113A (ko) | 티아디아졸 유도체 | |
IL41564A (en) | Pharmaceutical compositions containing n-cyclohexylbenzylamine derivatives | |
IL42201A (en) | 2-((1-benzylcyclopentyl)-imino)pyrrolidine | |
JPH0539226A (ja) | サイトメガロウイルス感染症用薬剤 | |
KR800000452B1 (ko) | 벤젠설포닐-우레아의 제조방법 | |
KR800000449B1 (ko) | 벤젠설포닐-우레아의 제조방법 | |
KR800000450B1 (ko) | 벤젠설포닐-우레아의 제조방법 | |
SI8911427B (sl) | Postopek za pripravo soli ranitidina z bizmutoviml kompleksi karboksilnih kislin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20050722 Year of fee payment: 9 |
|
LAPS | Lapse due to unpaid annual fee |